Process Bone Grafts
in Hours.
Not Weeks.

Supercritical CO₂ technology decellularizes, defatts, sterilizes (SAL 10⁻⁶), and removes toxic residues in 1-4 hours — eliminating multi-day chemical washes while preserving ECM integrity and mechanical strength.

  • Zero solvent residues
  • 1-4 hour cycles
  • GMP – compliant processing
m2.5 encapsulator image
m2.5-Encapsulator

1-4 hrs

SAL 10⁻⁶

99.09%

31-37°C

The Limitations of Traditional Bone Graft Processing

Conventional decellularization and sterilization methods create production bottlenecks, leave toxic residues, and compromise the structural integrity of bone grafts.

  • Prolonged Production Cycles: Chemical detergent protocols take 3-14 days, with rinsing cycles adding days or weeks to remove cytotoxic chemicals like SDS. This creates inventory bottlenecks and delays patient access.
  • Toxic Residues: Detergent-based methods often fail to reduce residual SDS below the safe threshold of 0.002%, risking inflammation and fibrosis after implantation.
  • ECM Damage: SDS degrades proteins, dissolves glycosaminoglycans, denatures collagen, and weakens scaffold structure. Gamma irradiation reduces biomechanical strength.
  • High Immunogenic Risk: Standard methods remove only 30.18% of α-Gal antigens from xenografts, leaving significant immune response triggers in the final product.

Supercritical CO₂: Integrated
Processing in One Cycle

Supercritical CO₂ operates above 31.1°C and 7.38 MPa, leveraging dual gas-liquid properties to penetrate bone tissue, decellularize in 1-4 hours, and integrate multiple processing steps into a single cycle.

Hours, Not Weeks

🧬

Integrated Multi-Step Processing

🛡️

Zero Cytotoxic Residues

🎯

Superior Antigen Clearance

💪

Preserves Mechanical Strength

🏗️

Maintains ECM Architecture

Subcritical Water vs Traditional Solvents

Processing Time

Cytotoxic Residues

Operating Temperature

Sterilization Level

α-Gal Antigen Removal

ECM Preservation

Residual DNA

Process Integration

GMP Compliance

The Supercritical CO₂ Processing Cycle

1

Supercritical State Formation

CO₂ is pressurized above 7.38 MPa and heated above 31.1°C, creating a supercritical state with both gas and liquid properties for deep tissue penetration.

2

Decellularization & Defatting

Supercritical CO₂ penetrates dense bone tissue, removing cellular material and lipids in 1-4 hours while preserving the native porous architecture of cancellous bone.

3

Antigen & Residue Removal

Removes 99.09% of immunogenic α-Gal antigens from xenografts. Optional PAA additive enhances viral inactivation and breaks down to harmless acetic acid and water.

4

Terminal Sterilization

Achieves SAL 10⁻⁶ sterilization assurance level in the same cycle, meeting regulatory requirements for terminal sterilization without separate processing.

5

Complete Residue Removal

Upon depressurization, CO₂ reverts to gas and completely evaporates, leaving zero cytotoxic residues in the bone graft ECM. Ready for clinical use.

Clinical Performance Data

Bone grafts processed with supercritical CO₂ demonstrate superior clinical outcomes compared to traditional methods.

  • Enhanced Osteogenic Potential:
    SC-CO₂ decellularized bone shows greater bone formation potential than traditional DBM, with multiple bone formation centers and active growth observed soon after implantation.
  • Improved Cell Attachment
    Preserved porous structure with intact micropores facilitates mesenchymal stem cell (ASC) attachment and congregation, critical for successful bone healing.
  • Reduced Immune Response
    99.09% α-Gal removal and 13.49 ng/mg residual DNA significantly reduce immunogenic triggers compared to 30.18% antigen removal with standard methods.
  • Maintained Mechanical Properties
    Low-temperature processing preserves biomechanical strength better than steam sterilization, ethylene oxide, or gamma irradiation which degrade structural integrity.

GMP-Compliant Processing Systems

extraktLAB’s supercritical CO₂ systems meet GMP compliance standards with validated SAL 10⁻⁶ terminal sterilization, ensuring regulatory-ready bone graft production.

No pressure, no commitment. Just expert guidance to help you make the best decision for your business.